Therefore, the aim of the presented study was to search, using next generation sequencing (NGS) technology, for new, not previously studied UCP1 gene variants, that are potentially associated with MetS and/or T2DM risk. This evidence concerns the gene UCP1 and type 2 diabetes mellitus.